Hello Heart’s Blood Nail Blood Pressure Cuff and smartphone app empower users to manage their heart health and detect serious problems before they occur. Hello Heart, founded in 2013, has been added to follow medication reminders and clinic-based, personalized digital coaching to drive lifestyle change. This research is the largest multi-year study of digital therapy efficacy in controlling hypertension.
Researchers tracked 28,189 adults with health insurance using Hello Heart technology and programs. These include the fact that more and more people are busy with Halo digital digital therapy, and that their blood pressure improves, especially in those with stage II, the most severe form of hypertension.
“This is the first peer-reviewed, published study reporting the long-term experience of digital health applications for blood pressure management, with the intensity of the association clinically meaningful,” said Alex Beatty, MD, MD. AS, a cardiologist and colleague said. Professor at the University of California, San Francisco, and lead author of the study. “On average, participants have used Hello Heart for 25 weeks, a level of engagement I have not seen in digital yen digital hypertension management programs. Continuous engagement and systolic blood pressure reduction of more than 20 mmHg can increase the chance of a person’s heart attack, stroke, kidney disease and death.
Researchers found that for the majority of users, any level of engagement with the Halo Heart program was associated with a decrease in blood pressure. Furthermore, Hello Heart demonstrated the ability to capture hypertension crises in men and women and to destabilize them before timely identification of potential events. The results were statistically significant even after adjusting for demographic, socioeconomic status, and behavioral factors.
“There is a lot of skepticism and hypocrisy around hypertension management solutions because for years, no effective solution has been found, and current solutions produce less participant engagement. We are pleased that the study has shown strong clinical results that have been sustained for three years for Hello Heart users, ”said Maian Cohen, CEO of Helve Heart. “It can be very uncomfortable and frightening for companies to submit their results to peer review. We have been helping consumers’ heart health for many years and are proud of their clinical results through a peer-review process that confirms what we already have ates – hello strong to the heart , Has a sustainable clinical impact.